Andrew Sinclair, Director at Sierra Oncology, Inc. (SRRA), bought 437,471 shares at $27.00 ($7.8M) on 2022-01-31, disclosed to the SEC on 2022-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.20 | 287,471 | $3.8M | 48.4% |
| 2 | $27.00 | 150,000 | $4.0M | 51.6% |
| Total | $17.93 avg | 437,471 | $7.8M | 100% |
| Filing → |
| SLNO | BUY | 2019-10-29 | $2.8M | — | Filing → |
| SLNO | BUY | 2018-12-27 | $14.9M | — | Filing → |